Obesity, Metabolically Benign
9
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Tuna Based Nuggets and Ischemic Cardiomyopathy
Small Extracellular Vesicles and Insulin Action
Metabolomics and Bariatric Surgery in Patients With Metabolically Unhealthy Obesity
Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia
Life Style Modification Medical and Surgical Management in Patients With Obesity
Oxidative Stress, Inflammation, and Lipoprotein in Metabolic Syndrome
Effect of Diet and Physical Activity on Adipokines
Adiponectin, Leptin, h-CRP Values in Obese Children - Important Markers for Metabolic Syndrome?
High-intensity Interval Training in Overweight/Obese